ClinicalTrials.Veeva

Menu

Safe & Sound Protocol in Adults With Trauma and SUD

C

Caron Treatment Centers

Status

Not yet enrolling

Conditions

Substance Use Disorders
Anxiety
Posttraumatic Stress Symptom

Treatments

Device: Safe and Sound Protocol

Study type

Interventional

Funder types

Other

Identifiers

NCT07219056
Caron002

Details and patient eligibility

About

This study will explore whether the use of the Safe and Sound Protocol (SSP) app is an effective adjunct to treatment as usual (TAU) in individuals with co-occurring substance use disorders and trauma. This study will recruit 129 participants (100 completers) randomized to receive either active or sham SSP in addition to TAU. Participants will utilize the SSP for a minimum of three hours to a maximum of five hours for a total of seven days. Data will be collected at both pre- and post-test. Data to be collected will include measures on affect, anxiety, personality, mindfulness, and posttraumatic stress disorder symptoms. The SSP has shown effectiveness in reducing symptoms of anxiety, depression, and trauma symptoms in pilot studies conducted at other locations. This will be the first study to examine the effectiveness of SSP with individuals with co-occurring SUD and trauma.

Full description

The Safe and Sound Protocol (SSP) was developed by Dr. Stephen Porges based on his Polyvagal Theory that highlights the vagus nerve's influences on emotional and behavioral regulation, social connection, and fear/trauma responses.

Research examining the effectiveness of SSP with children and/or adults on the Autism Spectrum has shown improvement in social awareness and decline in auditory hypersensitivities and hypo-sensitivities, visual sensitivity, tactile hypersensitivities, selective eating and digestive problems. SSP has also been shown to reduce symptoms of anxiety, depression and autonomic reactivity in individuals engaged in speech therapy for voice and throat complaints.

There is on-going clinical research to examine the effectiveness of SSP in various populations, including those suffering from posttraumatic stress disorder (PTSD). In real-world data obtain through the SSP platform, just over half of individuals reporting clinical levels of PTSD symptoms as assessed on the Posttraumatic Checklist - 5 (PCL-5) had a reduction in symptoms to below the clinical threshold following the completion of SSP.

Safe and Sound Protocol (SSP) Core is five hours of music therapy that is progressively filtered through a patented algorithm that highlights middle sound frequencies, the frequency most associated with cues of safety from human speech. This is designed to stimulate the vagus nerve by engaging the middle ear muscles and nerves to move out of defensive state of activation and activate the social engagement and calming system of the nervous system. SSP is designed to help participants regulate their nervous system to support reduction in distress and increased social connection.

To date, there is no research underway to examine the effectiveness of SSP for individuals experiencing posttraumatic stress symptoms and a substance use disorder (SUD). Individuals experiencing posttraumatic stress symptoms and SUD are hypothesized to benefit from a non-invasive treatment designed to regulate their autonomic nervous system, such as SSP.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ages 18 years old to 75 years old
  • In residential treatment for substance use disorder.
  • Has a history of trauma and is enrolled in Caron's trauma programming
  • Is proficient in English
  • Able to provide written informed consent.
  • Stated willingness to comply with all study procedures and availability for the duration of the study.

Exclusion criteria

  • Does not speak English
  • Age < 18 or > 75
  • Does not have a history of trauma
  • Active psychosis
  • Active or uncontrolled seizures
  • Tinnitus
  • Active suicidal ideation
  • Actively engaging in self-injurious behavior
  • Severe neurological condition
  • Diagnosis of autism
  • Has any serious medical disease or mental health condition which, in the judgment of the Principal Investigator or his/her designee, would make study participation unsafe, or would make intervention compliance difficult.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups

Active SSP
Experimental group
Description:
Participants will engage with the SSP for a minimum of 3 hours and a maximum of 5 hours over the course of seven days.
Treatment:
Device: Safe and Sound Protocol
Sham SSP
Sham Comparator group
Description:
Participants will engage with the SSP for a minimum of 3 hours and a maximum of 5 hours over the course of seven days. The sham protocol will deliver unfiltered music.
Treatment:
Device: Safe and Sound Protocol

Trial contacts and locations

1

Loading...

Central trial contact

Dean Stankoski, MS; Erin Deneke, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems